119 related articles for article (PubMed ID: 8944834)
1. Imaging and staging of head and neck cancer using a low pH In-111-bleomycin complex.
Kairemo KJ; Ramsay HA; Paavonen T; Bondestam S
Eur J Cancer B Oral Oncol; 1996 Sep; 32B(5):311-21. PubMed ID: 8944834
[TBL] [Abstract][Full Text] [Related]
2. A low pH 111In-bleomycin complex: a tracer for radiochemotherapy of head and neck cancer.
Kairemo KJ; Ramsay H; Nikula TK; Hopsu EV; Taavitsainen MJ; Bondestam S; Hiltunen JV
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):135-9. PubMed ID: 7543289
[TBL] [Abstract][Full Text] [Related]
3. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.
Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE
Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096
[TBL] [Abstract][Full Text] [Related]
4. Biokinetics of indium-111-bleomycin complex in head and neck cancer--implementations for radiochemotherapy.
Kairemo KJ; Ramsay HA; Paavonen TK; Jääskelä-Saari HA; Tagesson M; Ljunggren K; Strand SE
Cancer Detect Prev; 1997; 21(1):83-90. PubMed ID: 9043768
[TBL] [Abstract][Full Text] [Related]
5. Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines.
Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R
Int J Radiat Biol; 1998 May; 73(5):565-70. PubMed ID: 9652815
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell cancer cell lines: sensitivity to bleomycin and suitability for animal xenograft studies.
Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R
Acta Otolaryngol Suppl; 1997; 529():241-4. PubMed ID: 9288321
[TBL] [Abstract][Full Text] [Related]
7. Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice.
Jääskelä-Saari HA; Grénman R; Ramsay HA; Tarkkanen J; Paavonen T; Kairemo KJ
Cancer Biother Radiopharm; 2005 Aug; 20(4):426-35. PubMed ID: 16114991
[TBL] [Abstract][Full Text] [Related]
8. Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC.
Hou DY; Hamburger AW; Beach JL; Maruyama Y
Cancer Invest; 1989; 7(6):543-50. PubMed ID: 2483533
[TBL] [Abstract][Full Text] [Related]
9. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
10. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.
Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM
J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cobalt 57 tagged bleomycin as a clinical aid in staging of head and neck carcinoma.
Cummings CW; Larson SM; Dobie RA; Weymuller EA; Rudd TG; Merello A
Laryngoscope; 1981 Apr; 91(4):529-37. PubMed ID: 6163936
[TBL] [Abstract][Full Text] [Related]
12. Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex.
Hou DY; Maruyama Y
J Surg Oncol; 1990 May; 44(1):5-9. PubMed ID: 1692949
[TBL] [Abstract][Full Text] [Related]
13. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy.
Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM
J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055
[TBL] [Abstract][Full Text] [Related]
14. Imaging of olfactory neuroblastoma by In-111 bleomycin complex.
Jekunen AP; Kairemo KJ; Ramsay HA; Kajanti MJ
Clin Nucl Med; 1996 Feb; 21(2):129-31. PubMed ID: 8697683
[TBL] [Abstract][Full Text] [Related]
15. Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results.
Brink I; Klenzner T; Krause T; Mix M; Ross UH; Moser E; Nitzsche EU
Nuklearmedizin; 2002 Apr; 41(2):108-13. PubMed ID: 11989297
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.
Drugs R D; 2004; 5(5):293-6. PubMed ID: 15357628
[TBL] [Abstract][Full Text] [Related]
18. Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex.
Hou DY; Ordonez JV; Cross RJ; Ross DD; Maruyama Y
J Surg Oncol; 1989 Feb; 40(2):73-8. PubMed ID: 2464720
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of 111In-labeled bleomycin in patients with brain tumors: compartmental vs. non-compartmental models.
Ryynänen PM; Savolainen SE; Aronen HJ; Korppi-Tommola ET; Huhmar HM; Kallio ME; Hiltunen JV
Ann Nucl Med; 1998 Dec; 12(6):313-21. PubMed ID: 9972368
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
